Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy

PURPOSE: To determine whether the presence of vitreomacular interface abnormalities (VMIA) in patients with diabetic macular oedema (DMO) modifies the response to ranibizumab. METHODS: Medical records and spectral-domain optical coherence tomography (SD-OCT) scans of consecutive patients with centre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhail, Michael, Stewart, Stephen, Seow, Felicia, Hogg, Ruth, Lois, Noemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060772/
https://www.ncbi.nlm.nih.gov/pubmed/29779188
http://dx.doi.org/10.1007/s00417-018-4009-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060772/
https://www.ncbi.nlm.nih.gov/pubmed/29779188
http://dx.doi.org/10.1007/s00417-018-4009-6

Ejemplares similares